CRISPR Therapeutics AG (CRSP)
61.78
-1.78
(-2.80%)
USD |
NASDAQ |
Jun 17, 16:00
61.74
-0.04
(-0.06%)
After-Hours: 18:53
CRISPR Therapeutics Revenue (Annual): 370.00M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 370.00M |
| December 31, 2022 | 0.436M |
| December 31, 2021 | 913.08M |
| December 31, 2020 | 0.543M |
| December 31, 2019 | 289.59M |
| Date | Value |
|---|---|
| December 31, 2018 | 3.124M |
| December 31, 2017 | 41.00M |
| December 31, 2016 | 5.164M |
| December 31, 2015 | 0.247M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.436M
Minimum
2022
913.08M
Maximum
2021
314.73M
Average
289.59M
Median
2019
Revenue (Annual) Benchmarks
| Vertex Pharmaceuticals Inc | 9.869B |
| Intellia Therapeutics Inc | 36.28M |
| Novartis AG | 46.66B |
| MoonLake Immunotherapeutics | -- |
| Regeneron Pharmaceuticals Inc | 13.12B |